1832 Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.22M | Sell |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $81.8M | Buy |
|
|||||
|
2024
Q2 | $1.91M | Buy |
|
|||||
|
2024
Q1 | $1.72M | Sell |
|
|||||
|
2023
Q4 | $71.1M | Buy |
|
|||||
|
2023
Q3 | $41.9M | Buy |
|
|||||
|
2023
Q2 | $33M | Buy |
|
|||||
|
2023
Q1 | $14.7M | Sell |
|
|||||
|
2022
Q4 | $117M | Sell |
|
|||||
|
2022
Q3 | $119M | Buy |
|
|||||
|
2022
Q2 | $99.6M | Buy |
|
|||||
|
2022
Q1 | $38.1M | Buy |
|
|||||
|
2021
Q4 | $34.7M | Buy |
|
|||||
|
2021
Q3 | $25.4M | Buy |
|
|||||
|
2021
Q2 | $9.17M | Hold |
|
|||||
|
2021
Q1 | $8.28M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $119M | Buy |
|
|||||
|
2020
Q1 | $3.22M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.05M | Sell |
|
|||||
|
2015
Q2 | $1.57M | Sell |
|
|||||
|
2015
Q1 | $1.69M | Buy |
|
|||||
|
2014
Q4 | $1.12M | Sell |
|
|||||
|
2014
Q3 | $1.41M | Buy |
|
|||||
|
2014
Q2 | $1.21M | Hold |
|
|||||
|
2014
Q1 | $1.29M | Sell |
|
|||||
|
2013
Q4 | $1.51M | Buy |
|
|||||
|
2013
Q3 | $1.1M | Buy |
|